Featured

Children’s ibuprofen, Frigidaire gas ranges pulled

Taro Pharmaceuticals: Children’s Ibuprofen Oral Suspension (Berry Flavor)

  • The Issue: According to the official FDA Recall D-0390-2026 Enforcement Report, approximately 89,592 bottles of this generic pain reliever were manufactured with a significant contamination defect. Consumers reported finding a “gel-like mass and black particles” suspended within the liquid medication.

  • The Hazard: Classified as a Class II Recall, the FDA warns that the foreign substance could cause temporary or medically reversible adverse health consequences. The affected product is specifically the 4-ounce (120 mL) bottles from Lots 7261973A and 7261974A with an expiration date of January 31, 2027.

  • Remedy: Parents should stop using the medication immediately. The recall was voluntarily initiated by Strides Pharma Inc., which manufactured the product for Taro. Consumers can contact Taro Pharmaceuticals U.S.A. for refund information.

Electrolux Group: Frigidaire / Frigidaire Gallery / Professional Gas Ranges

  • The Issue: As detailed in CPSC Recall 26-333, approximately 174,800 units sold between June 2025 and January 2026 contain a defective bake burner. The burner experiences “delayed ignition,” allowing gas to accumulate before finally lighting.

  • The Hazard: This delay creates a sudden flash or burst of flame when the oven is activated. There have been 62 reports of delayed ignition to date, resulting in 30 documented burn injuries.

  • Safety Status: Consumers are advised to immediately stop using the oven function of the range. The cooktop burners remain safe for use.

  • Remedy: Electrolux is providing free, professional in-home installation of a redesigned bake burner. Owners can verify their unit at the official Frigidaire Recall Support Portal by checking serial numbers in the range VF52200000 through VF54399999.


This article was constructed with the assistance of artificial intelligence and published by a member of The Washington Times’ AI News Desk team. The contents of this report are based solely on The Washington Times’ original reporting, wire services, and/or other sources cited within the report. For more information, please read our AI policy AI policy or contact Steve Fink, Director of Artificial Intelligence, at sfink@washingtontimes.com


The Washington Times AI Ethics Newsroom Committee can be reached at aispotlight@washingtontimes.com.

Source link

Related Posts

1 of 2,007